ODOMZO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, New Zealand, Poland, Spain.

Active ingredients

The drug ODOMZO contains one active pharmaceutical ingredient (API):

1
UNII W421AI34UW - SONIDEGIB PHOSPHATE
 

Sonidegib is an orally bioavailable inhibitor of the Hh signalling pathway. It binds to Smoothened (Smo), a G protein-coupled receptor-like molecule that positively regulates the Hh pathway. Aberrant Hh signalling has been linked to the pathogenesis of several types of cancer, including basal cell carcinoma (BCC). Sonidegib binding to Smo will inhibit Hh signalling and consequently block signal transduction.

 
Read more about Sonidegib

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ODOMZO Hard capsule MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01XJ02 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XJ Hedgehog pathway inhibitors
Discover more medicines within L01XJ02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 11304Y
CA Health Products and Food Branch 02500337
EE Ravimiamet 1695179, 1695180
ES Centro de información online de medicamentos de la AEMPS 1151030002
FI Lääkealan turvallisuus- ja kehittämiskeskus 401494
FR Base de données publique des médicaments 65006905
IL מִשְׂרַד הַבְּרִיאוּת 7835
IT Agenzia del Farmaco 044480010, 044480022
LT Valstybinė vaistų kontrolės tarnyba 1077881, 1077884
NZ Medicines and Medical Devices Safety Authority 19858
PL Rejestru Produktów Leczniczych 100354002
US FDA, National Drug Code 47335-303

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.